WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
THRD
THIRD HARMONIC BIO INC
$425.87M$10.46N/AN/AN/AN/AN/AN/AN/AN/A
DSGN
DESIGN THERAPEUTICS INC
$212.42M$3.76$4.5019.68%Hold2N/AN/AN/AN/A
SLNO
SOLENO THERAPEUTICS INC
$1.21B$37.34$60.7562.69%Strong Buy4N/AN/AN/AN/A
VRNA
VERONA PHARMA PLC
$1.24B$15.31$33.67119.90%Strong Buy3N/AN/AN/AN/A
EPIX
ESSA PHARMA INC
$270.74M$6.12$17.00177.78%Buy1N/AN/AN/AN/A
NUVB
NUVATION BIO INC
$573.90M$2.62$6.60151.91%Strong Buy5N/AN/AN/AN/A
MACK
MERRIMACK PHARMACEUTICALS INC
$213.82M$14.73N/AN/AN/AN/AN/AN/AN/AN/A
GDTC
CYTOMED THERAPEUTICS LTD
$25.39M$2.20$5.00127.27%Buy1N/AN/AN/AN/A
MNOV
MEDICINOVA INC
$64.74M$1.32N/AN/AN/AN/AN/AN/A-30.66%-28.86%
PTIX
PROTAGENIC THERAPEUTICS INC
$6.96M$1.57N/AN/AN/AN/AN/AN/AN/AN/A
ENTX
ENTERA BIO LTD
$70.96M$2.00$10.00400.00%Buy1N/AN/AN/AN/A
SNPX
SYNAPTOGENIX INC
$4.79M$4.41N/AN/AN/AN/AN/AN/AN/AN/A
IOVA
IOVANCE BIOTHERAPEUTICS INC
$3.22B$11.54$25.50120.97%Strong Buy8616.37%N/AN/AN/A
MTNB
MATINAS BIOPHARMA HOLDINGS INC
$39.36M$0.18N/AN/AN/AN/AN/AN/AN/AN/A
SCPH
SCPHARMACEUTICALS INC
$156.84M$4.35$18.00313.79%Buy1138.89%N/AN/AN/A
TNGX
TANGO THERAPEUTICS INC
$782.25M$7.33$17.00131.92%Strong Buy31.25%N/AN/AN/A
RCUS
ARCUS BIOSCIENCES INC
$1.34B$14.73$38.60162.05%Strong Buy53.34%N/AN/AN/A
APLS
APELLIS PHARMACEUTICALS INC
$5.78B$47.93$78.8664.53%Strong Buy1458.28%N/AN/AN/A
CTMX
CYTOMX THERAPEUTICS INC
$108.35M$1.60$3.1395.31%Hold2-9.84%N/AN/AN/A
ABVX
ABIVAX SA
$990.50M$15.74$18.0014.36%Buy211.87%N/AN/AN/A
GNLX
GENELUX CORP
$89.19M$3.32$31.00833.73%Buy2939.62%N/AN/AN/A
INMB
INMUNE BIO INC
$195.41M$10.84N/AN/AN/AN/AN/AN/AN/AN/A
AFMD
AFFIMED NV
$74.31M$4.88$13.33173.22%Buy347.04%N/AN/AN/A
PRAX
PRAXIS PRECISION MEDICINES INC
$700.04M$52.88$103.0094.78%Strong Buy4234.75%N/AN/AN/A
ORGS
ORGENESIS INC
$17.31M$0.50N/AN/AN/AN/AN/AN/AN/AN/A
ONVO
ORGANOVO HOLDINGS INC
$9.92M$0.99N/AN/AN/AN/A47.99%N/AN/AN/A
APM
APTORUM GROUP LTD
$28.40M$5.48N/AN/AN/AN/AN/AN/AN/AN/A
IBRX
IMMUNITYBIO INC
$3.44B$5.11$5.00-2.15%Hold1574.96%N/AN/AN/A
HRTX
HERON THERAPEUTICS INC
$383.34M$2.55$5.50115.69%Buy217.75%N/AN/AN/A
ADAP
ADAPTIMMUNE THERAPEUTICS PLC
$262.16M$1.06N/AN/AN/AN/A45.96%N/AN/AN/A
MGX
METAGENOMI INC
$252.56M$6.74$21.40217.51%Strong Buy56.65%N/AN/AN/A
PHAT
PHATHOM PHARMACEUTICALS INC
$532.14M$9.10$21.33134.43%Buy3651.65%N/AN/AN/A
PRQR
PROQR THERAPEUTICS NV
$159.46M$1.96$3.3872.19%Buy418.65%N/AN/AN/A
CHRS
COHERUS BIOSCIENCES INC
$217.54M$1.93$9.33383.58%Strong Buy328.83%N/AN/AN/A
FTRE
FORTREA HOLDINGS INC
$3.25B$36.35$38.144.93%Buy73.45%N/AN/AN/A
CDXC
CHROMADEX CORP
$255.30M$3.39$6.0076.99%Strong Buy218.04%N/AN/AN/A
TSHA
TAYSHA GENE THERAPIES INC
$430.14M$2.30$7.00204.35%Strong Buy6-31.15%N/AN/AN/A
OABI
OMNIAB INC
$518.87M$4.43$9.00103.16%Strong Buy435.15%N/AN/AN/A
NBTX
NANOBIOTIX SA
$278.56M$5.91$11.0086.13%Buy1-0.86%N/AN/AN/A
AUTL
AUTOLUS THERAPEUTICS PLC
$1.08B$4.08$9.50132.84%Strong Buy2368.18%N/AN/AN/A
BYSI
BEYONDSPRING INC
$88.57M$2.27N/AN/AN/AN/A400.43%N/AN/AN/A
FBIO
FORTRESS BIOTECH INC
$33.08M$1.72$12.50626.74%Strong Buy225.32%N/AN/AN/A
ELAB
ELEVAI LABS INC
$11.68M$0.67N/AN/AN/AN/AN/AN/AN/AN/A
SYBX
SYNLOGIC INC
$21.66M$1.86$15.50733.33%Buy286.35%N/AN/AN/A
INZY
INOZYME PHARMA INC
$267.47M$4.33$17.00292.61%Strong Buy4N/AN/AN/AN/A
ZURA
ZURA BIO LTD
$157.81M$3.62$16.00341.99%Buy1N/AN/AN/AN/A
NAUT
NAUTILUS BIOTECHNOLOGY INC
$295.23M$2.36N/AN/AN/AN/AN/AN/AN/AN/A
RZLT
REZOLUTE INC
$103.03M$2.60$9.75275.00%Strong Buy4N/AN/AN/AN/A
IMAB
I-MAB
$149.62M$1.81$8.00341.99%Strong Buy3-7.89%N/AN/AN/A
NMRA
NEUMORA THERAPEUTICS INC
$1.44B$9.06$26.50192.49%Strong Buy2N/AN/AN/AN/A
ALVR
ALLOVIR INC
$91.90M$0.80$1.1745.88%Hold3N/AN/AN/AN/A
OLMA
OLEMA PHARMACEUTICALS INC
$549.64M$9.83$22.50128.89%Strong Buy4N/AN/AN/AN/A
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
$2.70B$42.25$77.0082.25%Strong Buy8N/AN/AN/AN/A
HEPA
HEPION PHARMACEUTICALS INC
$7.06M$1.29N/AN/AN/AN/AN/AN/AN/AN/A
ONCT
ONCTERNAL THERAPEUTICS INC
$24.42M$8.25$34.00312.12%Strong Buy2-3.06%N/AN/AN/A
XERS
XERIS BIOPHARMA HOLDINGS INC
$238.77M$1.70$5.00194.12%Strong Buy316.29%N/AN/AN/A
IVVD
INVIVYD INC
$246.79M$2.07$9.50358.94%Strong Buy4N/AN/AN/AN/A
ATXI
AVENUE THERAPEUTICS INC
$5.18M$0.12$56.2547,976.92%Strong Buy1N/AN/AN/AN/A
TRML
TOURMALINE BIO INC
$410.34M$16.00$61.00281.25%Strong Buy4N/AN/AN/AN/A
EWTX
EDGEWISE THERAPEUTICS INC
$1.48B$15.94$32.75105.46%Strong Buy4N/AN/AN/AN/A
GOVX
GEOVAX LABS INC
$3.19M$1.47$120.008,063.27%Buy1N/AN/AN/AN/A
ELDN
ELEDON PHARMACEUTICALS INC
$50.12M$2.02$13.00543.56%Buy1N/AN/AN/AN/A
GOSS
GOSSAMER BIO INC
$151.14M$0.67$8.601,183.58%Strong Buy5N/AN/AN/AN/A
FBRX
FORTE BIOSCIENCES INC
$26.90M$0.74$2.75272.12%Strong Buy1N/AN/AN/AN/A
INTS
INTENSITY THERAPEUTICS INC
$53.81M$3.93$12.00205.73%Buy1N/AN/AN/AN/A
TSBX
TURNSTONE BIOLOGICS CORP
$66.99M$2.90N/AN/AN/AN/AN/AN/AN/AN/A
RCKT
ROCKET PHARMACEUTICALS INC
$2.00B$22.10$54.33145.85%Strong Buy6N/AN/AN/AN/A
CRVS
CORVUS PHARMACEUTICALS INC
$72.58M$1.48$5.25254.73%Buy2N/AN/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$125.10M$3.92$33.00741.84%Strong Buy3N/AN/AN/AN/A
CRGX
CARGO THERAPEUTICS INC
$719.56M$18.28$29.6762.29%Strong Buy3N/AN/AN/AN/A
COGT
COGENT BIOSCIENCES INC
$624.52M$6.01$13.67127.40%Buy6N/AN/AN/AN/A
RNAC
CARTESIAN THERAPEUTICS INC
$112.82M$20.90$47.00124.88%Buy336.39%N/AN/AN/A
SRZN
SURROZEN INC
$27.54M$8.61N/AN/AN/AN/AN/AN/A-160.63%-132.23%
THTX
THERATECHNOLOGIES INC
$59.77M$1.30N/AN/AN/AN/A19.17%N/AN/AN/A
RLMD
RELMADA THERAPEUTICS INC
$111.64M$3.70N/AN/AN/AN/AN/AN/AN/AN/A
REPL
REPLIMUNE GROUP INC
$377.53M$6.15$37.67512.47%Strong Buy3N/AN/AN/AN/A
DRTS
ALPHA TAU MEDICAL LTD
$167.21M$2.40$8.00233.33%Strong Buy3N/AN/AN/AN/A
ADTX
ADITXT INC
$4.21M$2.53N/AN/AN/AN/A25.00%N/AN/AN/A
CTNM
CONTINEUM THERAPEUTICS INC
N/A$15.99N/AN/AN/AN/AN/AN/AN/AN/A
COYA
COYA THERAPEUTICS INC
$122.59M$8.43$14.0066.07%Strong Buy1N/AN/AN/AN/A
VRPX
VIRPAX PHARMACEUTICALS INC
$3.42M$2.92N/AN/AN/AN/AN/AN/AN/AN/A
RAPT
RAPT THERAPEUTICS INC
$271.42M$7.80$21.00169.23%Buy6N/AN/AN/AN/A
APVO
APTEVO THERAPEUTICS INC
$362.76k$0.68N/AN/AN/AN/AN/AN/AN/AN/A
ACHL
ACHILLES THERAPEUTICS PLC
$31.80M$0.77$2.83266.02%Hold3N/AN/AN/AN/A
BCAB
BIOATLA INC
$108.22M$2.25$9.50322.22%Buy2N/AN/AN/AN/A
ADCT
ADC THERAPEUTICS SA
$366.43M$4.44$9.33110.20%Strong Buy327.34%N/AN/AN/A
CARM
CARISMA THERAPEUTICS INC
$68.13M$1.64$7.50357.32%Strong Buy257.65%N/AN/AN/A
QNRX
QUOIN PHARMACEUTICALS LTD
$2.32M$0.63$4.00534.92%Strong Buy1N/AN/AN/AN/A
ALXO
ALX ONCOLOGY HOLDINGS INC
$846.07M$16.87$18.258.18%Strong Buy4N/AN/AN/AN/A
NNVC
NANOVIRICIDES INC
$13.07M$1.11$6.50485.59%Strong Buy1N/AN/AN/AN/A
ATHE
ALTERITY THERAPEUTICS LTD
$12.67M$2.26$4.0076.99%Buy1N/AN/AN/AN/A
LXEO
LEXEO THERAPEUTICS INC
$324.29M$12.16$21.2074.34%Strong Buy5N/AN/AN/AN/A
SRRK
SCHOLAR ROCK HOLDING CORP
$1.09B$13.96$27.0093.41%Strong Buy4N/AN/AN/AN/A
SNTI
SENTI BIOSCIENCES INC
$12.77M$0.28N/AN/AN/AN/A48.38%N/AN/AN/A
MIRA
MIRA PHARMACEUTICALS INC
$13.30M$0.90N/AN/AN/AN/AN/AN/AN/AN/A
IMVT
IMMUNOVANT INC
$4.03B$27.75$51.3384.98%Strong Buy9N/AN/AN/AN/A
VIGL
VIGIL NEUROSCIENCE INC
$95.16M$2.58$18.50617.05%Hold4N/AN/AN/AN/A
IRON
DISC MEDICINE INC
$654.54M$26.52$69.60162.44%Buy5N/AN/AN/AN/A
MURA
MURAL ONCOLOGY PLC
$59.74M$3.53$13.00268.27%Strong Buy1N/AN/AN/AN/A
IPA
IMMUNOPRECISE ANTIBODIES LTD
$31.42M$1.19$7.00486.26%Buy215.55%N/AN/AN/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -30.41% over the past year, underperforming other biotech stocks by -7 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 45.94% from Incyte's current stock price of $51.18.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -8.91% over the past year, overperforming other biotech stocks by 15 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 29.05% from Harmony Biosciences Holdings's current stock price of $28.93.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)


Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock lose -1.33% over the past year, overperforming other biotech stocks by 22 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 176.28% from Voyager Therapeutics's current stock price of $7.42.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)


Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 14.87%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 56.45%, which is 42 percentage points higher than the biotech industry average of 14.87%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.09%, which is -14 percentage points lower than the biotech industry average of 14.87%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.43% in the last day, and down -0.98% over the last week. Acrivon Therapeutics was the among the top losers in the biotechnology industry, dropping -10.84% yesterday.

Acrivon Therapeutics shares are trading higher after the company reported initial clinical data for ACR-368 and pipeline program progress today at a corporate R&D event.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -21.04% in the past year. It has overperformed other stocks in the biotech industry by 3 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)


Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has dropped -1.33% in the past year. It has overperformed other stocks in the biotech industry by 22 percentage points.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -30.41% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

49.03% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 94.43% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 15.41x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.